Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical t…
$8.36-1.18%
报价 2026-11-06
市值
$38.1M
EV
$59.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -6.1%
$4.31$8.90
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HBIOHarvard Bioscience, Inc. | $38.1M | -1.2% | +3.1% | 53% | – | 11.2x | 7.4x | |
| COSMCosmos Health Inc. | $30.7M | +5.2% | +60.2% | 10.3% | – | – | – | |
| TAOXTAO Synergies Inc. | $20.4M | +8.3% | – | 99.9% | – | – | – | |
| RVPRetractable Technologies, Inc. | $16.9M | -0.1% | – | – | – | – | – | |
| FEMYFemasys Inc. | $11.5M | +4.6% | +52.0% | 52.2% | – | – | – | |
| CLGNCollPlant Biotechnologies Ltd. | $7.5M | +0.8% | – | -521.7% | – | – | – | |
| NCNANuCana plc | $5.7M | +0.4% | – | 0% | – | – | – | |
| NXGLNEXGEL, Inc. | $1.8M | -12.6% | +173.9% | 35.1% | – | – | – | |
| NXLNexalin Technology, Inc. | $1.1M | +5.0% | +50.0% | -148.4% | – | – | – | |
| 同行中位数 | – | – | +56.1% | 10.3% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。